MediciNova FY2025 net loss per share $0.24, operating loss $13.3M, cash down to $30.8M

MEDICINOVA INC

2025-FY EPS reported -$0.24 revenue$409,657

Net loss attributable to shareholders $12.0M ($0.24 per share) vs $11.0M ($0.23) in FY2024.
Operating loss widened to $13.3M from $12.7M; net sales (collaboration revenue) totaled $0.41M.
Cash and equivalents fell to $30.8M from $40.4M; shareholders' equity decreased to $41.6M.
No dividend paid; FY2026 guidance withheld due to uncertainty around out-licensing activities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.